Compounded Tirzepatide Compounded Semaglutide Same active ingredient as Ozempic & Wegovy GLP-1 receptor agonist (single target) Average weight loss: ~15% of body weight Once-weekly subcutaneous injection Gradual dose titration over 48 weeks Well-studied safety profile Good starting option for most patients Compounded Tirzepatide Same active ingredient as Mounjaro & Zepbound Dual GLP-1 + GIP receptor agonist Average weight loss: up to 21% of body weight Once-weekly subcutaneous injection Gradual dose titration over 48 weeks Additional blood sugar regulation via GIP pathway May be more effective for patients with insulin resistance Not sure which is right for you
El perfil que ms se ve en consulta: la mujer en perimenopausia/menopausia El perfil ms frecuente es el de una mujer entre 40 y 60 aos, en perimenopausia o menopausia, que ha probado mltiples enfoques dietticos sin resultado
Well discuss your medical history, lifestyle, and goals to ensure your weight management plan is both safe and effective
Injection burden 1-2 injections/session Best for Dose flexibility and timing control Cycle driver Compound-specific adjustment Tesamorelin Loading 1-2 mg Frequency Once daily Maintenance 1-2 mg Route SubQ Ipamorelin Loading 200-300 mcg Frequency 1-2x daily Maintenance 200-300 mcg Route SubQ Weekly Schedule Example Monday Tesamorelin (PM) + Ipamorelin (AM) Tuesday Tesamorelin (PM) + Ipamorelin (AM) Wednesday Tesamorelin (PM) + Ipamorelin (AM) Thursday Tesamorelin (PM) + Ipamorelin (AM) Friday Tesamorelin (PM) + Ipamorelin (AM) Saturday Optional rest or continue Sunday Optional rest or continue Use separate syringes for separate vials
The Summer Motivation Factor Theres something about summer that makes us want to feel lighter, stronger, and more vibrant